Blood biomarkers representing maternal-fetal interface tissues used to predict early-and late-onset preeclampsia but not COVID-19 infection

BACKGROUND: A well-known blood biomarker (soluble fms-like tyrosinase-1 [sFLT-1]) for preeclampsia, i.e., a pregnancy disorder, was found to predict severe COVID-19, including in males. True biomarker may be masked by more-abrupt changes related to endothelial instead of placental dysfunction. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Sufriyana, Herdiantri, Salim, Hotimah Masdan, Muhammad, Akbar Reza, Wu, Yu-Wei, Su, Emily Chia-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359600/
https://www.ncbi.nlm.nih.gov/pubmed/35966044
http://dx.doi.org/10.1016/j.csbj.2022.08.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359600/
https://www.ncbi.nlm.nih.gov/pubmed/35966044
http://dx.doi.org/10.1016/j.csbj.2022.08.011

Ejemplares similares